logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Christopher J. Swearingen

New York University
H指数:33
被引数:4,343

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessing Rheumatoid Arthritis Disease Activity Measures in Ethnic Minority Patients in the United States

评估美国少数民族患者类风湿关节炎疾病活动度测量指标

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
IF1.8
2025-12-010
PRE
Quinones, Mercedes; Dowell, Sharon; Perez Alamino, Rodolfo; Swearingen, Christopher J.; Treadwell, Edward; Garcia-Valladares, Ignacio; Lawrence-Ford, Theresa; Lawrence-Elliott, Cynthia; Ince, Akgun; Sherrer, Yvonne; Mosley-Williams, Angelia; Yazici, Yusuf; Kerr, Gail S.
Biochemical biomarkers of knee osteoarthritis progression: Results from the FNIH biomarkers consortium progress OA study

膝关节骨关节炎进展的生物化学生物标志物：FNIH生物标志物联盟进展OA研究的结果

OSTEOARTHRITIS AND CARTILAGE OPEN
IF2.8
2025-09-011
OAAI
Collins, Jamie E.; Robinson, Douglas; Arden, Nigel; Bay-Jensen, Anne Christine; Deveza, Leticia A.; Karsdal, Morten; Ladel, Christoph; Perry, Thomas A.; Swearingen, Christopher J.; Hunter, David J.; Kraus, Virginia B.
A Phase 3, 28-week, multicentre, randomised, double-blind, placebo-controlled trial (OA-10) to evaluate the efficacy and safety of a single injection of lorecivivint in the target knee joint of moderately to severely symptomatic osteoarthritis patients

一项为期28周的III期、多中心、随机、双盲、安慰剂对照试验（OA-10），旨在评估中度至重度症状性骨关节炎患者靶膝关节单次注射lorecivivint的疗效和安全性。

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
IF3.3
2024-03-030
PRE
Yazici, Y.; Tambiah, J. R. S.; Swearingen, C. J.; Lopez, V. A.; Kennedy, S.; Fineman, M. S.; Simsek, I.; Solomon, E.; McAlindon, T. E.
Tau pathology reduction with SM07883, a novel, potent, and selective oral DYRK1A inhibitor: A potential therapeutic for Alzheimer's disease

Tau病理减少与SM07883，一种新的，有效的，选择性的口服DYRK1A抑制剂: 阿尔茨海默病的潜在治疗

AGING CELL
IF7.1
2019-07-0345
OAAI
Melchior, Benoit; Mittapalli, Gopi Kumar; Lai, Carolyn; Duong-Polk, Karen; Stewart, Joshua; Guner, Bora; Hofilena, Brian; Tjitro, Amanda; Anderson, Scott D.; Herman, David S.; Dellamary, Luis; Swearingen, Christopher J.; Sunil, K. C.; Yazici, Yusuf
A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study

一种新型Wnt途径抑制剂SM04690，用于治疗中度至重度膝骨关节炎: 一项为期24周的随机对照1期研究的结果

OSTEOARTHRITIS AND CARTILAGE
IF9
2017-10-01105
OAAI
Yazici, Y.; McAlindon, T. E.; Fleischmann, R.; Gibofsky, A.; Lane, N. E.; Kivitz, A. J.; Skrepnik, N.; Armas, E.; Swearingen, C. J.; DiFrancesco, A.; Tambiah, J. R. S.; Hood, J.; Hochberg, M. C.

研究方向

暂未获取到该数据
Y
Yusuf Yazıcı
H 指数:52论文数:416被引数:1.0万
J
J. Tambiah
H 指数:16论文数:76被引数:1,255
T
Timothy E. McAlindon
H 指数:66论文数:354被引数:2.6万
T
Theodore Pincus
H 指数:101论文数:640被引数:5.3万
A
Allan Gibofsky
H 指数:40论文数:183被引数:5,747
A
A. DiFrancesco
H 指数:9论文数:31被引数:675
N
Nancy E. Lane
H 指数:105论文数:762被引数:3.8万
G
Gail S. Kerr
H 指数:41论文数:159被引数:1.4万
M
Michiaki Imamura
H 指数:38论文数:188被引数:4,232
İ
İsmail Şimşek
H 指数:18论文数:108被引数:997